Michael Reedijk
- Oncology top 2%
- Cancer Cells and Metastasis 9
- Cancer Research top 2%
- Breast Cancer Treatment Studies 6
- Molecular Biology top 5%
- Developmental Biology and Gene Regulation 10
- Metabolism, Diabetes, and Cancer 5
- TGF-β signaling in diseases 5
- Immunology and Allergy top 5%
- Immunology top 5%
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 5
-
- Breast Lesions and Carcinomas 6
- Co-authors
- Tony PawsonDavid R. McCreadySean E. EganHui ZhangGina LockwoodNaomi MillerX. Johné LiuSilvia Odorcic
- Journals
- Molecular and Cellular Biology (5 papers)Cancer Research (4 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Michael Reedijk
49 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 1.4k
- Cancer Research 731
- Molecular Biology 2.4k
- Immunology and Allergy 192
- Immunology 634
Countries citing papers authored by Michael Reedijk
This map shows the geographic impact of Michael Reedijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Reedijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Reedijk more than expected).
Fields of papers citing papers by Michael Reedijk
This network shows the impact of papers produced by Michael Reedijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Reedijk. The network helps show where Michael Reedijk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Reedijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 49 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 32 | |
| 8 | 2018 | 85 | |
| 9 | 2017 | 92 | |
| 10 | 2016 | 52 | |
| 11 | 2015 | 62 | |
| 12 | 2014 | 38 | |
| 13 | 2013 | 19 | |
| 14 | 2011 | 53 | |
| 15 | 2011 | 49 | |
| 16 | 2009 | 131 | |
| 17 | 2008 | 10 | |
| 18 | High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survivalbreakdown → | 2005 | 615 |
| 19 | 2005 | 35 | |
| 20 | 1990 | 39 |
About Michael Reedijk
Michael Reedijk is a scholar working on Oncology, Immunology and Cancer Research, having authored 50 papers that have together received 3.7k indexed citations. Recurring topics across this work include Developmental Biology and Gene Regulation (10 papers), Cancer Cells and Metastasis (9 papers), Breast Cancer Treatment Studies (6 papers), Immune cells in cancer (6 papers), Breast Lesions and Carcinomas (6 papers), Immunotherapy and Immune Responses (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and TGF-β signaling in diseases (5 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (731 citations) and Molecular Biology (2.4k citations). Michael Reedijk has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Tony Pawson, David R. McCready, Sean E. Egan, Hui Zhang, Gina Lockwood, Naomi Miller, X. Johné Liu, Silvia Odorcic, Lynn Chang and Alan Bernstein. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.